Literature DB >> 7594226

Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan.

R Takeda1, T Matsubara, I Miyamori, H Hatakeyama, T Morise.   

Abstract

The incidence of vascular complications in 224 patients with aldosterone-producing adenoma (APA) which was proven on adrenal surgery, was compared to that in 224 sex- and age-matched patients with essential hypertension (EHT). The incidence of cerebral hemorrhage was significantly higher (p < 0.05) in the patients with APA when compared to the EHT group. On the other hand, the incidence of myocardial infarction and/or congestive heart failure in the APA group was lower, although this difference did not reach statistical significance. Diastolic blood pressure in the APA group was significantly higher (p < 0.001) in the EHT group. However, a significant difference in diastolic blood pressure was not detected between the APA groups with and without vascular complications, whereas in the EHT group diastolic blood pressure was significantly higher (p < 0.001) in cases with vascular complications as compared to those without complications. As a possible factor contributing to the higher incidence of cerebral hemorrhage in the APA group, proteinuria was suggested. It was recommended that patients with primary aldosteronism should undergo operation when localization of the APA is established.

Entities:  

Mesh:

Year:  1995        PMID: 7594226     DOI: 10.1007/BF03347840

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  7 in total

Review 1.  CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

Authors:  J W CONN; R F KNOPF; R M NESBIT
Journal:  Am J Surg       Date:  1964-01       Impact factor: 2.565

2.  Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism.

Authors:  D G Beevers; J J Brown; J B Ferriss; R Fraser; A F Lever; J I Robertson; M Tree
Journal:  Q J Med       Date:  1976-07

3.  Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.

Authors:  J H Laragh
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

4.  Lack of association between plasma-renin and history of heart-attack or stroke in patients with essential hypertension.

Authors:  W J Mroczek; F A Finnerty; K J Catt
Journal:  Lancet       Date:  1973-09-01       Impact factor: 79.321

5.  Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors:  H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal:  N Engl J Med       Date:  1972-03-02       Impact factor: 91.245

6.  Are patients with essential hypertension and low renin protected against stroke and heart attack?

Authors:  R Stroobandt; R Fagard; A K Amery
Journal:  Am Heart J       Date:  1973-12       Impact factor: 4.749

7.  Plasma renin levels and vascular complications in hypertension.

Authors:  A E Doyle; G Jerums; C I Johnston; W J Louis
Journal:  Br Med J       Date:  1973-04-28
  7 in total
  38 in total

Review 1.  Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue?

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

2.  Acute cerebral hemorrhage normalized plasma renin activity in a patient with primary aldosteronism.

Authors:  Tetsuya Hiraiwa; Ranko Ibata; Keiji Tanimoto; Naomune Yamamoto; Jungo Terasaki; Haruhito Azuma; Akihisa Imagawa; Toshiaki Hanafusa
Journal:  Endocrine       Date:  2009-10-28       Impact factor: 3.633

3.  Shortened saline infusion test for subtype prediction in primary aldosteronism.

Authors:  Kazutaka Nanba; Mika Tsuiki; Hironobu Umakoshi; Aya Nanba; Yuusuke Hirokawa; Takeshi Usui; Tetsuya Tagami; Akira Shimatsu; Tomoko Suzuki; Akiyo Tanabe; Mitsuhide Naruse
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

Review 4.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 5.  Antihypertensive Therapies and Cognitive Function: a Review.

Authors:  Nisharahmed Kherada; Todd Heimowitz; Clive Rosendorff
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

Review 6.  A comprehensive review of the clinical aspects of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

Review 7.  MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism.

Authors:  Gregory L Hundemer; Anand Vaidya
Journal:  Eur J Endocrinol       Date:  2020-12       Impact factor: 6.664

8.  Comparison of C-arm computed tomography and on-site quick cortisol assay for adrenal venous sampling: A retrospective study of 178 patients.

Authors:  Chin-Chen Chang; Bo-Ching Lee; Yeun-Chung Chang; Vin-Cent Wu; Kuo-How Huang; Kao-Lang Liu
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

Review 9.  Aldosterone receptor antagonists: biology and novel therapeutical applications.

Authors:  P Magni; M Motta
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

10.  Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation.

Authors:  Sophocles Chrissobolis; Grant R Drummond; Frank M Faraci; Christopher G Sobey
Journal:  J Hypertens       Date:  2014-09       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.